http://www.reuters.com/article/2015/07/02/us-health-bacteriophages-insight-idUSKCN0PC1FO20150702
Two plates coated with drug-resistant bacteria with a mutation called NDM 1 and then exposed to various antibiotics are seen at the Health Protection Agency in north London, Britain in this March 9, 2011 file photo.
The ultrastructural appearance of a single virus particle of the measles virus.
Robert Beall, president of the Bethesda-based Cystic Fibrosis Foundation, led the group’s decision in the late 1990s to invest in a small California biotechnology firm. (Amanda Voisard for The Washington Post)
In the not-too-distant future, the U.S. Supreme Court’s 6-3 decision in King v. Burwell will be viewed as a significant turning point for the Affordable Care Act (ACA). Simply stated, the ACA is not only the law of the land — it will remain the law of the land. And I believe that the Court’s decision foreshadows an end to the contentious and partisan fights about the ACA’s existence; slowly but surely, a search for common purpose on health care will begin among conservatives and progressives, Republicans and Democrats.
Survey: Over five years, mental health benefits, lifestyle coaching on the rise
A new PricewaterhouseCoopers report on medical cost trends highlights how specialty drugs are outpacing traditional drugs in a major way.
https://www.linkedin.com/pulse/obamacare-future-healthcare-kalon-mitchell
As everyone knows by now, the Supreme Court upheld the constitutionality of state healthcare insurance exchanges subsidized by the federal government. If this decision had gone the other way, it could have had a significant impact on the percentage of insured patients currently, and in the coming years. With this decision, this key component of Obamacare seems to be a permanent part of the future financial core of healthcare reimbursement.
As the nation’s top five health insurance companies jockey through merger proposals that could leave just three large companies at the top, a big question is, what does it mean for consumers – and the rest of the industry?
